TriSalus Life Sciences, Inc. SEC filings TLSI

TriSalus Life Sciences, Inc. has 493 filings in SEC EDGAR's recent list, going back to Oct 29, 2020. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 22, 2026 (other events). The company's fiscal year ends on December 31.

TriSalus Life Sciences, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Oct 7, 2026 Oct 5, 2026
4 Insider transaction Oct 7, 2026 Oct 5, 2026
4 Insider transaction Oct 7, 2026 Oct 5, 2026
4 Insider transaction Oct 7, 2026 Oct 5, 2026
8-K Current report
Other events
Sep 22, 2026 Sep 22, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 7, 2026 —
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
5 Annual insider ownership Jul 1, 2026 Dec 31, 2025
4 Insider transaction Jul 1, 2026 Jun 30, 2026
5 Annual insider ownership Jul 1, 2026 Dec 31, 2025
4 Insider transaction Jun 29, 2026 Jun 29, 2026
3 Initial insider ownership Jun 29, 2026 Jun 29, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 20, 2026 —
4 Insider transaction May 19, 2026 May 15, 2026
4 Insider transaction May 18, 2026 May 15, 2026
4 Insider transaction May 18, 2026 May 15, 2026
4 Insider transaction May 18, 2026 May 15, 2026
4 Insider transaction May 18, 2026 May 15, 2026
4 Insider transaction May 18, 2026 May 15, 2026
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
8-K Current report
Shareholder vote results
May 14, 2026 May 14, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
SCHEDULE 13G Ownership over 5% (passive) May 12, 2026 —
8-K Current report
Officer or director change
Apr 29, 2026 Apr 24, 2026
4 Insider transaction Apr 20, 2026 Jul 31, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 7, 2026 Apr 1, 2026
4 Insider transaction Apr 1, 2026 Jul 31, 2025
ARS Annual report to shareholders Mar 31, 2026 Dec 31, 2025
DEFA14A Additional proxy material Mar 31, 2026 —
DEF 14A Proxy statement Mar 31, 2026 Dec 31, 2025
4 Insider transaction Mar 20, 2026 Mar 11, 2026
4 Insider transaction Mar 20, 2026 Mar 11, 2026
4 Insider transaction Mar 20, 2026 Mar 11, 2026
4 Insider transaction Mar 20, 2026 Mar 11, 2026
4 Insider transaction Mar 20, 2026 Mar 11, 2026
S-8 Employee stock plan registration Mar 10, 2026 —
10-K Annual report Mar 5, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 5, 2026 Mar 5, 2026
424B5 Prospectus supplement Feb 26, 2026 —
4 Insider transaction Feb 23, 2026 Feb 23, 2026
4 Insider transaction Feb 23, 2026 Feb 23, 2026
4 Insider transaction Feb 23, 2026 Feb 23, 2026
4 Insider transaction Feb 23, 2026 Feb 23, 2026
4 Insider transaction Feb 23, 2026 Feb 23, 2026
424B5 Prospectus supplement Feb 20, 2026 —
8-K Current report
Material agreement, Other events
Feb 20, 2026 Feb 19, 2026
424B5 Prospectus supplement Feb 19, 2026 —
4 Insider transaction Feb 11, 2026 Feb 4, 2026
3 Initial insider ownership Feb 11, 2026 Feb 4, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 9, 2026 Feb 3, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
EFFECT Filing Dec 4, 2025 —
CORRESP Letter to the SEC Dec 2, 2025 —
4 Insider transaction Nov 25, 2025 Nov 24, 2025
4 Insider transaction Nov 25, 2025 Nov 24, 2025
4 Insider transaction Nov 25, 2025 Feb 13, 2024
4 Insider transaction Nov 25, 2025 Nov 24, 2025
4 Insider transaction Nov 25, 2025 Nov 24, 2025
4 Insider transaction Nov 25, 2025 Nov 24, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
S-3 Shelf registration Nov 13, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 3, 2025 —
8-K Current report
Officer or director change
Oct 1, 2025 Sep 30, 2025
4 Insider transaction Aug 29, 2025 Aug 28, 2025
8-K Current report
Officer or director change
Aug 29, 2025 Aug 25, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 18, 2025 —
4 Insider transaction Aug 15, 2025 Aug 14, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 4, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 1, 2025 —
SC TO-I/A Filing Jul 25, 2025 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
Jul 24, 2025 Jul 24, 2025
EFFECT Filing Jul 22, 2025 —
SC TO-I/A Filing Jul 15, 2025 —
S-4/A Filing Jul 11, 2025 —
3 Initial insider ownership Jul 10, 2025 Jul 1, 2025
4 Insider transaction Jun 27, 2025 Jun 12, 2025
4 Insider transaction Jun 27, 2025 Jun 12, 2025
4 Insider transaction Jun 27, 2025 Jun 12, 2025
4 Insider transaction Jun 27, 2025 Jun 12, 2025
4 Insider transaction Jun 27, 2025 Jun 12, 2025
4 Insider transaction Jun 27, 2025 Jun 12, 2025
4 Insider transaction Jun 27, 2025 Jun 12, 2025
8-K Current report
Other events
Jun 23, 2025 Jun 23, 2025
S-4 Registration for a merger or exchange Jun 23, 2025 —
SC TO-I Filing Jun 23, 2025 —
8-K Current report
Shareholder vote results
Jun 16, 2025 Jun 12, 2025
EFFECT Filing Jun 11, 2025 —
CORRESP Letter to the SEC Jun 6, 2025 —
UPLOAD Letter from the SEC Jun 6, 2025 —
EFFECT Filing May 30, 2025 —
S-3 Shelf registration May 30, 2025 —
8-K Current report
Officer or director change, Other events
May 30, 2025 May 23, 2025
10-K/A Amended annual report May 30, 2025 Dec 31, 2024
CORRESP Letter to the SEC May 28, 2025 —
4 Insider transaction May 21, 2025 May 19, 2025
4 Insider transaction May 21, 2025 May 19, 2025
4 Insider transaction May 21, 2025 May 19, 2025
4 Insider transaction May 21, 2025 May 19, 2025
4 Insider transaction May 21, 2025 May 19, 2025
4 Insider transaction May 21, 2025 May 19, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
D Filing May 8, 2025 —
UPLOAD Letter from the SEC May 5, 2025 —
EFFECT Filing May 2, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) May 2, 2025 —
CORRESP Letter to the SEC Apr 30, 2025 —
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 30, 2025 Jun 12, 2025
UPLOAD Letter from the SEC Apr 30, 2025 —
425 Filing Apr 30, 2025 —
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
Apr 30, 2025 Apr 30, 2025
S-3 Shelf registration Apr 28, 2025 —
S-8 Employee stock plan registration Apr 25, 2025 —
S-3 Shelf registration Apr 25, 2025 —
8-K Current report
Officer or director change
Apr 23, 2025 Apr 20, 2025
8-K Current report
Officer or director change
Apr 17, 2025 Apr 16, 2025
10-K Annual report Apr 15, 2025 Dec 31, 2024
NT 10-K Filing Mar 28, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 27, 2025 Mar 27, 2025
8-K Current report
Officer or director change
Feb 25, 2025 Feb 19, 2025
4 Insider transaction Feb 19, 2025 Feb 18, 2025
4 Insider transaction Feb 19, 2025 Feb 18, 2025
4 Insider transaction Feb 19, 2025 Feb 18, 2025
4 Insider transaction Feb 19, 2025 Feb 18, 2025
4 Insider transaction Feb 19, 2025 Feb 18, 2025
4 Insider transaction Feb 19, 2025 Feb 18, 2025
4 Insider transaction Feb 19, 2025 Feb 18, 2025
8-K Current report
New debt, Unregistered share sale
Feb 19, 2025 Feb 18, 2025
4 Insider transaction Feb 11, 2025 Feb 10, 2025
4 Insider transaction Feb 11, 2025 Feb 10, 2025
4 Insider transaction Feb 11, 2025 Feb 10, 2025
4 Insider transaction Feb 6, 2025 Feb 5, 2025
8-K Current report
Results of operations
Feb 3, 2025 Jan 31, 2025
4 Insider transaction Jan 31, 2025 Jan 29, 2025
3 Initial insider ownership Jan 31, 2025 Jan 29, 2025
4 Insider transaction Jan 31, 2025 Jan 29, 2025
3 Initial insider ownership Jan 31, 2025 Jan 29, 2025
4 Insider transaction Jan 31, 2025 Jan 29, 2025
8-K Current report
Officer or director change
Jan 31, 2025 Jan 29, 2025
4 Insider transaction Jan 29, 2025 Jan 27, 2025
4 Insider transaction Jan 29, 2025 Jan 27, 2025
4 Insider transaction Jan 29, 2025 Jan 27, 2025
4 Insider transaction Jan 29, 2025 Jan 27, 2025
4 Insider transaction Jan 29, 2025 Jan 27, 2025
4 Insider transaction Jan 29, 2025 Jan 27, 2025
4 Insider transaction Jan 29, 2025 Jan 27, 2025
8-K Current report
Results of operations
Jan 23, 2025 Jan 23, 2025
3 Initial insider ownership Jan 15, 2025 Jan 6, 2025
8-K Current report
Officer or director change
Jan 8, 2025 Jan 4, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
D Filing Dec 30, 2024 —
4 Insider transaction Dec 19, 2024 Oct 5, 2024
4 Insider transaction Dec 19, 2024 Dec 17, 2024
4 Insider transaction Dec 19, 2024 Dec 17, 2024
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 19, 2024 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 19, 2024 —
4 Insider transaction Dec 12, 2024 Dec 10, 2024
144 Notice of proposed sale Dec 10, 2024 —
SC 13G Ownership over 5% (passive) Dec 4, 2024 —
4 Insider transaction Nov 25, 2024 Nov 22, 2024
4 Insider transaction Nov 22, 2024 Nov 20, 2024
4 Insider transaction Nov 15, 2024 Nov 14, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
EFFECT Filing Nov 8, 2024 —
EFFECT Filing Nov 8, 2024 —
EFFECT Filing Nov 8, 2024 —
EFFECT Filing Nov 8, 2024 —
CORRESP Letter to the SEC Nov 6, 2024 —
POS AM Filing Nov 6, 2024 —
UPLOAD Letter from the SEC Nov 4, 2024 —
8-K Current report
Officer or director change
Nov 1, 2024 Oct 28, 2024
S-3 Shelf registration Oct 29, 2024 —
POS AM Filing Oct 29, 2024 —
POS AM Filing Oct 29, 2024 —
POS AM Filing Oct 29, 2024 —
SC 13G Ownership over 5% (passive) Oct 21, 2024 —
4 Insider transaction Sep 13, 2024 Sep 12, 2024
4 Insider transaction Sep 12, 2024 Sep 10, 2024
4 Insider transaction Sep 10, 2024 Aug 28, 2024
4 Insider transaction Aug 21, 2024 Aug 13, 2024
4 Insider transaction Aug 21, 2024 Aug 13, 2024
4 Insider transaction Aug 21, 2024 Aug 13, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
TLSI (Nasdaq), TLSIW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Westminster, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1826667
Former names
MedTech Acquisition Corp (until Aug 10, 2023); MedTech Acquisition Corporation (until Oct 29, 2020)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.